Wikidata entity: Q412236
C₁₆H₁₄F₃N₅O (P274)
Quantities
| P2067 | mass | 349.115 |
| P3780 | active ingredient in | ... | Q29006642 (Vfend) | Vfend |
| P3780 | active ingredient in | ... | Q29006668 (Voriconazole Accord) | Voriconazole Accord |
| P3780 | active ingredient in | ... | Q29006669 (Voriconazole Hospira) | Voriconazole Hospira |
| P233 | canonical SMILES | String | CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O | ??? |
| P373 | Commons category | String | Voriconazole | ??? |
| P703 | found in taxon | ... | Q10468906 (Dendrodochium) | Dendrodochium |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=CC=C(F)C=C3F | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q12192 (pneumonia) | pneumonia |
| P2175 | medical condition treated | ... | Q259626 (aspergillosis) | aspergillosis |
| P2175 | medical condition treated | ... | Q273510 (candidiasis) | candidiasis |
| P2175 | medical condition treated | ... | Q3392853 (lung disease) | lung disease |
| P2175 | medical condition treated | ... | Q5398631 (esophageal candidiasis) | esophageal candidiasis |
| P2175 | medical condition treated | ... | Q18553214 (systemic mycosis) | systemic mycosis |
| P2175 | medical condition treated | ... | Q18928476 (fusariosis) | fusariosis |
| P1748 | NCI Thesaurus ID | String | C1707 | ??? |
| P769 | significant drug interaction | ... | Q39111 (nifedipine) | nifedipine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q189522 (quinine) | quinine |
| P769 | significant drug interaction | ... | Q191521 (sildenafil) | sildenafil |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q412327 (nilotinib) | nilotinib |
| P769 | significant drug interaction | ... | Q417542 (sunitinib) | sunitinib |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q424161 (vardenafil) | vardenafil |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q795057 (cabozantinib) | cabozantinib |
| P769 | significant drug interaction | ... | Q894611 (bosutinib) | bosutinib |
| P769 | significant drug interaction | ... | Q907104 (ranolazine) | ranolazine |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P769 | significant drug interaction | ... | Q419186 (ergotamine) | ergotamine |
| P769 | significant drug interaction | ... | Q1257318 (bedaquiline) | bedaquiline |
| P769 | significant drug interaction | ... | Q3011604 (dabrafenib) | dabrafenib |
| P769 | significant drug interaction | ... | Q420323 (lapatinib) | lapatinib |
| P769 | significant drug interaction | ... | Q421136 (sorafenib) | sorafenib |
| P769 | significant drug interaction | ... | Q422645 (efavirenz) | efavirenz |
| P769 | significant drug interaction | ... | Q422654 (saquinavir) | saquinavir |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q7131441 (panobinostat) | panobinostat |
| P769 | significant drug interaction | ... | Q7157043 (pazopanib) | pazopanib |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q21011224 (eliglustat) | eliglustat |
| P769 | significant drug interaction | ... | Q21011233 (ceritinib) | ceritinib |
| P769 | significant drug interaction | ... | Q27126905 (docetaxel trihydrate) | docetaxel trihydrate |
| P769 | significant drug interaction | ... | Q27139135 (dasatinib monohydrate) | dasatinib monohydrate |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P3364 | stereoisomer of | ... | Q27166445 ((2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol) | (2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol |
| P3364 | stereoisomer of | ... | Q27253140 (ent-voriconazole) | ent-voriconazole |
| P3364 | stereoisomer of | ... | Q82568688 ((2R,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | (2R,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
| P279 | subclass of | ... | Q419639 (azole) | azole |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q578726 (antifungal) | antifungal |
| P2868 | subject has role | ... | Q50430402 (14-alpha demethylase inhibitor) | 14-alpha demethylase inhibitor |
| P2868 | subject has role | ... | Q50430512 (cytochrome P-450 CYP3A inhibitors) | cytochrome P-450 CYP3A inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | voriconazole | ??? |
Why not click here or view trends?
log id: 2715905